SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-015900
Filing Date
2016-04-05
Accepted
2016-04-05 17:00:11
Documents
3
Period of Report
2016-03-30
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mstx-8k_20160330.htm 8-K 55313
2 EX-10.1 mstx-ex101_6.htm EX-10.1 40889
3 EX-16.1 mstx-ex161_35.htm EX-16.1 7178
  Complete submission text file 0001564590-16-015900.txt   104899
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 500 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 161555255
SIC: 2834 Pharmaceutical Preparations